Cargando…

Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group

Immunoglobulin light chain amyloidosis is a rare, multisystemic, phenotypically heterogenous disease affecting cardiovascular, renal, neurological, and gastrointestinal systems to varying degrees. Its underlying cause is a plasma cell dyscrasia characterized by misfolding of monoclonal immunoglobuli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maurer, Mathew S., Dunnmon, Preston, Fontana, Mariana, Quarta, Cristina Candida, Prasad, Krishna, Witteles, Ronald M., Rapezzi, Claudio, Signorovitch, James, Lousada, Isabelle, Merlini, Giampaolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Advances in Heart Failure, Mechanical Circulatory Support and Transplant
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202961/ https://www.ncbi.nlm.nih.gov/pubmed/35331001 http://dx.doi.org/10.1161/CIRCHEARTFAILURE.121.009038

Ejemplares similares

Implications of Extra-cardiac Disease in Patient Selection for Heart Transplantation: Considerations in Cardiac Amyloidosis
por: Punnoose, Lynn Raju, et al.
Publicado: (2023)

Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
por: Agha, Ali M, et al.
Publicado: (2018)

Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis
por: Schrutka, Lore, et al.
Publicado: (2022)

Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?
por: Roger-Rollé, Aénora, et al.
Publicado: (2020)

Four-year outcomes with third-generation centrifugal left ventricular assist devices in an era of restricted transplantation
por: Özalp, Faruk, et al.
Publicado: (2014)

Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome
por: Moser, Bernhard, et al.
Publicado: (2018)

Lung transplantation after ex vivo lung perfusion in two Scandinavian centres
por: Nilsson, Tobias, et al.
Publicado: (2019)

Evaluation of right ventricular function using liver stiffness in patients with left ventricular assist device†
por: Kashiyama, Noriyuki, et al.
Publicado: (2017)

Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion
por: Andreasson, Anders S.I., et al.
Publicado: (2017)

Clinical impact and ‘natural’ course of uncorrected tricuspid regurgitation after implantation of a left ventricular assist device: an analysis of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS)
por: Veen, Kevin M, et al.
Publicado: (2020)

Efficacy of central extracorporeal life support for patients with fulminant myocarditis and cardiogenic shock
por: Tadokoro, Naoki, et al.
Publicado: (2021)

Survival and adverse events in patients with atrial fibrillation at left ventricular assist device implantation: an analysis of the European Registry for Patients with Mechanical Circulatory Support
por: Antonides, Christiaan F J, et al.
Publicado: (2022)

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis
por: Guendouz, Soulef, et al.
Publicado: (2022)

Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis
por: Brun, Stéphanie, et al.
Publicado: (2019)

Gently handling the acutely failing right ventricle … at last!
por: Lorusso, Roberto, et al.
Publicado: (2021)

Left ventricular assist devices and right ventricular failure prediction: Quo Vadis?
por: Lorusso, Roberto, et al.
Publicado: (2021)

Anticoagulation in syncardia total artificial heart recipients: anti-factor Xa or activated partial thromboplastin time?
por: Monteagudo-Vela, María, et al.
Publicado: (2021)

The influence of preoperative dialysis on survival after continuous-flow left ventricular assist device implantation
por: Lamba, Harveen K, et al.
Publicado: (2021)

Impact of pretransplant left ventricular assist device support duration on outcome after heart transplantation
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021)

Impact of the HeartMate 3 continuous-flow left ventricular assist device in patients with small body size
por: Tonai, Kohei, et al.
Publicado: (2022)

Results from a multicentre evaluation of plug use for left ventricular assist device explantation
por: Potapov, Evgenij V, et al.
Publicado: (2021)

Early posthospitalization recovery after extracorporeal membrane oxygenation in survivors of COVID-19
por: Taylor, Lauren J., et al.
Publicado: (2022)

Cannulate, extubate, ambulate approach for extracorporeal membrane oxygenation for COVID-19
por: Hayanga, J.W. Awori, et al.
Publicado: (2022)

Left ventricular assist device implants in patients on extracorporeal membrane oxygenation: do we need cardiopulmonary bypass?
por: Pappalardo, Federico, et al.
Publicado: (2021)

Role of left atrial appendage occlusion in patients with HeartMate 3
por: Melehy, Andrew, et al.
Publicado: (2021)

Long-term paracorporeal pulsatile mechanical circulatory support in adolescent and adult patients
por: Kremer, Jamila, et al.
Publicado: (2022)

Thoracic mediastinal-occupying ratio predicts recovery and prognosis after lung transplantation
por: Yoshiyasu, Nobuyuki, et al.
Publicado: (2022)

Failure to rescue: obesity increases the risk of mortality following early graft failure in heart transplantation in UNOS database patients
por: Herbst, David Alan, et al.
Publicado: (2022)

Extracorporeal membrane oxygenation circuits in parallel for refractory hypoxemia in patients with COVID-19
por: Patel, Yatrik J., et al.
Publicado: (2022)

Changes in haemodynamics during single lung transplantation under venovenous extracorporeal membrane oxygenation
por: Oishi, Hisashi, et al.
Publicado: (2022)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

Short-term outcomes of EXCOR Paediatric implantation
por: Komori, Motoki, et al.
Publicado: (2022)

Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022)

Bend relief fenestration might prevent outflow graft obstruction in patients with left ventricular assist device
por: Färber, Gloria, et al.
Publicado: (2022)

Evolution of extracorporeal membrane oxygenation trigger criteria in COVID-19 acute respiratory distress syndrome
por: Deitz, Rachel L., et al.
Publicado: (2022)

Worse survival in patients with right ventricular dysfunction and COVID-19–associated acute respiratory distress requiring extracorporeal membrane oxygenation: A multicenter study from the ORACLE Group
por: Cain, Michael T., et al.
Publicado: (2022)

Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy
por: Aurich, Matthias, et al.
Publicado: (2023)

Temporary venovenous extracorporeal membrane oxygenation after cardiopulmonary bypass in minimally invasive cardiac surgery via right minithoracotomy
por: Nakanaga, Hiroshi, et al.
Publicado: (2023)

Incremental cost-effectiveness of extracorporeal membranous oxygenation as a bridge to cardiac transplant or left ventricular assist device placement in patients with refractory cardiogenic shock
por: Reza, Joseph, et al.
Publicado: (2022)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d73hb3937pc31kua9sttb10avo